HSDT Increases Solana (SOL) Holdings to 2.3 Million as SOL Staking Yields Surpass Top Validators, While Stock Falls Over 50%
SOL/USDT
$3,875,175,794.90
$89.20 / $86.02
Change: $3.18 (3.70%)
-0.0160%
Shorts pay
Nasdaq-listed HSDT, formerly known as Helius Medical Technologies, disclosed a further expansion of its Solana exposure, adding approximately 100,000 SOL (about $20 million) and lifting total holdings to just over 2.3 million SOL. The move signals ongoing capital allocation toward high-liquidity on-chain assets.
The issuer notes that its staking yield averages above 7%, a touch higher than the ~6.7% seen among the leading ten validators, suggesting a resilient income stream within the validator ecosystem.
Despite gains in on-chain assets, HSDT shares have fallen more than 50% over the past month. Google Finance data show a trading price near $6.75 on Wednesday, well below October’s intraday high of around $14, underscoring elevated equity risk alongside crypto exposure.